Priventive effect of nepafenac ophtalmic solution for changing of foveal thickness after cataract surgery.

Priventive effect of nepafenac ophtalmic solution for changing of foveal thickness after cataract surgery. - Priventive effect of nepafenac ophtalmic solution for changing of foveal thickness after cataract surgery.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006671

Enrollment

Registered

2011-11-04

Start date

2011-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular edema after cataract surgery

Interventions

Period,Dose:Nepafenac was administrated three times per day from operation day to 6week after cataract surgery. Period.Dose:Nepafenac was administrated three times per day from operation day to 6week

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients of performede cataract surgery.Retinal thickness is less than 250 micrio meter.

Exclusion criteria

Exclusion criteria: Eyes of sever diabetic retinopathy, eyes allergic to nepafenac or steroid, eyes previously and post operatively underwent intraocular surgery of auy type, history of uveitis or presence of any retinal choloidal disease other than diabeties, patient with severe cardiac incompetence or cereberovascular disorder and patient undergo hemo dialysis.

Design outcomes

Primary

Measure	Time frame
Best corrected visual acuity, slit lamp microscopy, amount of anterior chamber flare and cells mesured laser flare cell photometry. Retinal thickness and foveal volum ware mesured by OCT3	—

Countries

Japan

Contacts

Public ContactEndo Naoko

Tokyo women's medical university diabetic center opthalmology depertment Tokyo women's medical university diabetic center opthalmology depertment

03-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026